BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27636874)

  • 1. Probable Drug-Related Meningioma Detected During the Course of Medication Review Services.
    Alderman CP
    Consult Pharm; 2016 Sep; 31(9):500-4. PubMed ID: 27636874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of meningiomas after discontinuation of cyproterone acetate in a transsexual patient.
    Cebula H; Pham TQ; Boyer P; Froelich S
    Acta Neurochir (Wien); 2010 Nov; 152(11):1955-6. PubMed ID: 20811919
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cyproterone acetate and meningioma: The latest findings].
    Schmutz JL
    Ann Dermatol Venereol; 2018 May; 145(5):390-391. PubMed ID: 29703641
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study.
    Weill A; Nguyen P; Labidi M; Cadier B; Passeri T; Duranteau L; Bernat AL; Yoldjian I; Fontanel S; Froelich S; Coste J
    BMJ; 2021 Feb; 372():n37. PubMed ID: 33536184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyproterone acetate and risk of meningioma: a nationwide cohort study.
    Mikkelsen AP; Greiber IK; Scheller NM; Hilden M; Lidegaard Ø
    J Neurol Neurosurg Psychiatry; 2022 Feb; 93(2):222-223. PubMed ID: 34187864
    [No Abstract]   [Full Text] [Related]  

  • 6. Growth of a meningioma in a transsexual patient after estrogen-progestin therapy.
    Gazzeri R; Galarza M; Gazzeri G
    N Engl J Med; 2007 Dec; 357(23):2411-2. PubMed ID: 18057351
    [No Abstract]   [Full Text] [Related]  

  • 7. Abrupt regression of a meningioma after discontinuation of cyproterone treatment.
    Gonçalves AM; Page P; Domigo V; Méder JF; Oppenheim C
    AJNR Am J Neuroradiol; 2010 Sep; 31(8):1504-5. PubMed ID: 20053802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review.
    Mancini I; Rotilio A; Coati I; Seracchioli R; Martelli V; Meriggiola MC
    Gynecol Endocrinol; 2018 Jun; 34(6):456-459. PubMed ID: 29105524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Should cyproterone acetate be removed from our prescriptions?].
    Plu-Bureau G
    Gynecol Obstet Fertil Senol; 2019 Dec; 47(12):823-824. PubMed ID: 31634588
    [No Abstract]   [Full Text] [Related]  

  • 10. A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas.
    Lee KS; Zhang JJY; Kirollos R; Santarius T; Nga VDW; Yeo TT
    Sci Rep; 2022 Feb; 12(1):1942. PubMed ID: 35121790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary report of patients with meningiomas exposed to Cyproterone Acetate, Nomegestrol Acetate and Chlormadinone Acetate - Monocentric ongoing study on progestin related meningiomas.
    Devalckeneer A; Aboukais R; Bourgeois P; De Witte O; Racape J; Caron S; Perbet R; Maurage CA; Lejeune JP
    Clin Neurol Neurosurg; 2021 Nov; 210():106959. PubMed ID: 34592677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First case of cyproterone acetate induced multiple meningiomas in identical female twins: A case report.
    Batchinsky-Parrou V; Barraud S; Kleiber JC; Litre F
    Neurochirurgie; 2022 Apr; 68(3):323-326. PubMed ID: 33989640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is cyproterone acetate causing intracranial meningiomas?
    Majid Z; Kareem R
    J Pak Med Assoc; 2022 Oct; 72(10):2144. PubMed ID: 36661024
    [No Abstract]   [Full Text] [Related]  

  • 14. Meningiomas after cyproterone acetate exposure: Case reports in twin sisters.
    de Germay S; Lafaurie M; Dupuy M; de Germay B
    Therapie; 2021; 76(3):255-257. PubMed ID: 32418729
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-dose cyproterone acetate treatment of sexual acting out in men with dementia.
    Haussermann P; Goecker D; Beier K; Schroeder S
    Int Psychogeriatr; 2003 Jun; 15(2):181-6. PubMed ID: 14620076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocols for the use of cyproterone, medroxyprogesterone, and leuprolide in the treatment of paraphilia.
    Reilly DR; Delva NJ; Hudson RW
    Can J Psychiatry; 2000 Aug; 45(6):559-63. PubMed ID: 10986575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatocellular carcinoma in a healthy liver possibly due to long-term use of cyproterone acetate].
    Manfredi S; Lenfant L; Gresset AC; Bonnotte B; Lorcerie B; Chauffert B
    Presse Med; 2000 Nov; 29(36):1983. PubMed ID: 11149080
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormonal therapies and meningioma: is there a link?
    Cea-Soriano L; Blenk T; Wallander MA; Rodríguez LA
    Cancer Epidemiol; 2012 Apr; 36(2):198-205. PubMed ID: 21943794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and Progesterone Therapy and Meningiomas.
    Hage M; Plesa O; Lemaire I; Raffin Sanson ML
    Endocrinology; 2022 Feb; 163(2):. PubMed ID: 34935947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma.
    Samarut E; Lugat A; Amelot A; Scharbarg E; Hadjadj S; Primot C; Loussouarn D; Thillays F; Buffenoir K; Cariou B; Drui D; Roualdes V
    J Neurooncol; 2021 Mar; 152(1):115-123. PubMed ID: 33392938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.